Daeppen J B, Schoenfeld-Smith K, Smith T L, Schuckit M A
Department of Psychiatry, Veterans Affairs Medical Center, San Diego, California 92161-2002, USA.
J Stud Alcohol. 1999 Sep;60(5):589-94. doi: 10.15288/jsa.1999.60.589.
This article examines characteristics of a subgroup of alcohol dependent men with very elevated serum Gamma-Glutamyltransferase (GGT) activity.
GGT was measured in 196 men soon after admission to an inpatient alcohol and drug treatment program. Subjects were split into two groups based on the a priori GGT value of > or =150 U/L for Group 1 (n = 20), and <150 U/L for Group 2 (n = 176). Serum aspartate amino-transferase (AST), serum alanine amino-transferase (ALT) and mean corpuscular volume (MCV), as well as several aspects of the drinking history, were compared cross-sectionally between the two groups. The stability of GGT in the context of drinking was evaluated prospectively over 12 months in a subsample of 35 individuals.
Most measures of the drinking pattern and severity of dependence were similar between the two groups, although subjects in Group 1 demonstrated higher levels for AST (p < .01), MCV (p < .01) and ALT (p < .01). Subjects in Group 1 reported more drinking days per month (23.8 +/- 3.98 vs 17.8 +/- 8.71, t = 5.43, p < .001), and more related history of alcoholic liver disease (30.0% vs 8.5%, chi2 = 8.66, p < .01). In the presence of the variables significantly different between the two groups, AST, the number of drinking days per month and the proportion with alcoholic liver disease predicted membership to Group 1, although their influence was moderate (pseudo R between 0.16 and 0.20). The correlation between GGT at intake and follow-up in 35 individuals who returned to drinking was r = .56, p < .001, while two out of three subjects with high GGT at intake were also high at follow-up.
Subjects with very high GGT seem to demonstrate a more intense vulnerability to alcohol, a characteristic which appears to be stable over time.
本文研究血清γ-谷氨酰转移酶(GGT)活性极高的酒精依赖男性亚组的特征。
在196名男性入院接受住院酒精和药物治疗项目后不久测量其GGT。根据先验GGT值将受试者分为两组,第一组(n = 20)GGT值≥150 U/L,第二组(n = 176)GGT值<150 U/L。对两组的血清天冬氨酸氨基转移酶(AST)、血清丙氨酸氨基转移酶(ALT)、平均红细胞体积(MCV)以及饮酒史的几个方面进行横断面比较。在35名个体的子样本中,前瞻性地评估了12个月内饮酒情况下GGT的稳定性。
两组之间大多数饮酒模式和依赖严重程度的指标相似,尽管第一组受试者的AST(p <.01)、MCV(p <.01)和ALT(p <.01)水平较高。第一组受试者每月报告的饮酒天数更多(23.8±3.98对17.8±8.71,t = 5.43,p <.001),酒精性肝病相关病史更多(30.0%对8.5%,χ2 = 8.66,p <.01)。在两组之间显著不同的变量中,AST、每月饮酒天数和酒精性肝病患者比例可预测第一组成员身份,尽管其影响中等(伪R在0.16至0.20之间)。35名恢复饮酒个体的入院时GGT与随访时GGT之间的相关性为r =.56,p <.001,入院时GGT高的三名受试者中有两名在随访时也高。
GGT极高的受试者似乎对酒精表现出更强的易感性,这一特征似乎随时间稳定。